The regulation of arterial blood pressure is a complex physiological process involving the nervous system, hormonal pathways, and the direct properties of vascular and cardiac muscle. When this regulation fails, hypertension often ensues. To manage these conditions, pharmacology provides several classes of drugs that target specific points in these regulatory loops. This article explores the classification of antihypertensive agents, ranging from those that dampen sympathetic nervous system activity to those that interfere with systemic humoral signals and ion channel function.
Drugs Reducing the Stimulating Effect of Adrenergic Innervation
The sympathetic nervous system plays a primary role in increasing blood pressure through the release of norepinephrine, which stimulates adrenoreceptors. Drugs that reduce this "neurotropic" effect can act at various levels of the neural pathway, from the brain to the synapse.
1. Drugs Decreasing the Tone of the Vasomotor Centers
These agents act centrally within the brain to reduce the sympathetic outflow from the vasomotor centers. By lowering the "command" signal sent to the periphery, they reduce blood pressure. Key examples include Clonidine, Methyldopa, Guanfacine, and Moxonidine.
2. Ganglioblockers and Sympatholytics
If the signal cannot be stopped at the brain, it can be blocked further down the line:
- Ganglioblockers: These drugs block autonomic ganglia, effectively severing the communication between the central nervous system and the effector organs. Examples include Azamethonium (pentamium) and Trepirium (hygronium).
- Sympatholytics: These drugs act at the very end of the nerve, suppressing adrenergic neurons at the level of the presynaptic endings. Reserpine is a classic example of this mechanism.
Keep reading for free.
Create an account to finish this reading and make it part of your study routine.
Continue reading freeAlready have an account? Log in
Updated